10th INTEREST – Presentations Thursday, 5 May, 2016

Tuesday 3 MayWednesday 4 MayThursday 5 MayFriday 6 May
 Session: HIV Prevention in 2016
  Sustaining Progress on Scale-Up of Valuntary Medical Male Circumcision (VMMC), Including Role of Devices and Early Infant Male Circumcision
Dr. Z. Mwandi, USAID, Malawi
  Trial, Post-Trial & Demonstration Project Results for Pre-Exposure Prophylaxis (PrEP)
Dr. E. Irungu, Partners in Health Research and Development, Kenya
 New Evidence on PrEP for Women in Africa: Gels, Rings, Injectables and More
Dr. N. Mgodi, University of Zimbabwe-UCSF, Zimbabwe
 Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PrEP) Implementation
 PrEP
Dr. C. Hankins, AIGHD, Canada/The Netherlands
 Speaker for the Proposition
Dr. E. Katabira, Makere University, Uganda
 Speaker for the Opposition
Dr. F. Venter, University of Witwatersrand, South Africa
 Community Advocate
Dr. S. Watiti, Mildmay Hospital, Uganda
 Session: Oral Abstracts
 Predictors for HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience
Dr. C. Carty, South Africa
 EDCTP As a Model For Europe-Africa Partnership on HIV/AIDS Research and Capacity Development
Dr. L. Pandya, The Netherlands
 Accumulation of HIV-1 drug Resistance After Continued Virological Failure on First-Line Antiretroviral Therapy in Adults and Children
Dr. T. Boender, The Netherlands
 Tenofovir-Containing First-Line ART Favourably Reduces Inflammation Markers Compared to Thymidine Analogue Nucleoside Reverse-Transcriptase Inhibitors
Dr. S. Kroeze, The Netherlands
 Session: Prevention Tools: Implementation and Discovery
 HIV Reservoirs in Developing Countries: Implication for HIV CURE Strategies
Dr. C. Kityo, Joint Clinical Research Centre, Uganda
  Update on HIV Vaccine Startegies and Trials: Active and Passive Immunization Strategies
Dr. H. Kibuuka, Makerere University, Uganda
 Session: Progress and Challenges in Reaching Key Populations
 Sex Work in Sub-Saharan Africa: Opportunities and Challenges
Dr. I. Traore, Centre MURAZ, Burkina Faso
 Drugs and HIV in Africa: Challenges and Opportunities
Dr. R. Abdool, United Nations Office of Drugs and Crime, Mauritius
 Risks, Vulnerabilities and Burden of HIV Among Men Who Have Sex With Men Across Sub-Saharan Africa
Dr. I. Njindam, CHAMP, Cameroon
 Session: Poster Discussions
 Finding the First 90% To Achieve Epidemic Control
Dr. J. Masedza, Zambia
 Operational research studies among MSM in Cameroon: linkage to treatment challenges
Dr. U. Tamoufe, Cameroon
 Pre-Clinical Evaluation of Optimized Immunogens Targeting the Neutralizing Epitopes in MPER of HIV-1 Envelope Glycoprotein
Dr. G. Nchinda, USA
 HIV-1 group O in Cameroon: 10 Years Evolution, 2006-2013 - Prevalence & Diversity
Dr. A. Aghokeng, Cameroon
 The effect of antiretroviral naïve HIV-1 infection on the ability of autologous Natural Killer cells to produce IFNy upon exposure to Plasmodium falciparum- infected Erythrocytes
Dr. C. Ngane, Cameroon
 Evaluating Plasmatic Biomarkers as Disease Signatures for the Point of Care Monitoring of HIV-1 and Comorbidities in Resource Limited Regions
Dr. G. Nchinda, Cameroon
 Immune Reconstitution and Skewed Responses After ART Start in HIV Infected Ugandans
Dr. K. Makamdop, Uganda
  Outcomes of Second-line Therapy in HIV Positive Adults Attending for Routine Care at Yaoundé Central Hospital
Dr. A. Fopoussi, Cameroon